Search Results - "FOOT, N"

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms by Rack, K. A., van den Berg, E., Haferlach, C., Beverloo, H. B., Costa, D., Espinet, B., Foot, N., Jeffries, S., Martin, K., O’Connor, S., Schoumans, J., Talley, P., Telford, N., Stioui, S., Zemanova, Z., Hastings, R. J.

“…Cytogenomic investigations of haematological neoplasms, including chromosome banding analysis, fluorescence in situ hybridisation (FISH) and microarray…”
Get full text

A sensible protocol by Foot, N

Get full text

Selection, engineering, and in vivo testing of a human leukocyte antigen-independent T-cell receptor recognizing human mesothelin by Hiscox, Martyn J, Wasmuth, Alexandra, Williams, Chris L, Foot, Jaelle N, Wiedermann, Guy E, Fadda, Valeria, Boiani, Sara, Cornforth, Terri V, Wikiert, Karolina A, Bruton, Shaun, Cartwright, Neil, Anderson, Victoria Elizabeth, Barnes, Christopher S, Vieira, Joao V, Birch-Machin, Ian, Gerry, Andrew B, Miller, Karen, Pumphrey, Nicholas J

“…Canonical α/β T-cell receptors (TCRs) bind to human leukocyte antigen (HLA) displaying antigenic peptides to elicit T cell-mediated cytotoxicity…”
Get full text

Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68 by Feracci, Mikael, Foot, Jaelle N., Grellscheid, Sushma N., Danilenko, Marina, Stehle, Ralf, Gonchar, Oksana, Kang, Hyun-Seo, Dalgliesh, Caroline, Meyer, N. Helge, Liu, Yilei, Lahat, Albert, Sattler, Michael, Eperon, Ian C., Elliott, David J., Dominguez, Cyril

“…Sam68 and T-STAR are members of the STAR family of proteins that directly link signal transduction with post-transcriptional gene regulation. Sam68 controls…”
Get full text

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH) by Rack, K. A., van den Berg, E., Haferlach, C., Beverloo, H. B., Costa, D., Espinet, B., Foot, N., Jeffries, S., Martin, K., O’Connor, S., Schoumans, J., Talley, P., Telford, N., Stioui, S., Zemanova, Z., Hastings, R. J.

Get full text

Screening protein – Single stranded RNA complexes by NMR spectroscopy for structure determination by Foot, Jaelle N., Feracci, Mikael, Dominguez, Cyril

“…In the past few years, RNA molecules have been revealed to be at the center of numerous biological processes. Long considered as passive molecules transferring…”
Get full text

ALK rearrangements in EBUS-derived transbronchial needle aspiration cytology in lung cancer by Neat, M. J., Foot, N. J., Hicks, A., Breen, R., Wilkins, B., McLean, E., Santis, G.

“…Objectives Patients with non‐small cell lung cancer (NSCLC) positive for anaplastic lymphoma kinase (ALK) gene rearrangements may be treated successfully with…”
Get full text

A sensible protocol by Foot, N.

Get full text

Drosophila Ndfip is a novel regulator of Notch signaling by Dalton, H E, Denton, D, Foot, N J, Ho, K, Mills, K, Brou, C, Kumar, S

“…In the Drosophila wing, the Nedd4 ubiquitin ligases (E3s), dNedd4 and Su(dx), are important negative regulators of Notch signaling; they ubiquitinate Notch,…”
Get full text

Results from First Pilot CEQAS for Myeloma Genetic Diagnosis by Talley, P.J, Foot, N, O’Connor, S.JM, Schoumans, J, Hastings, R.J

Get full text

Cartridge size by Foot, N

Get full text

Recent Advances into Understanding Some Aspects of the Structure and Function of Mammalian and Avian Lungs by Maina, J. N., West, J. B., Orgeig, S., Foot, N. J., Daniels, C. B., Kiama, S. G., Gehr, P., Mühlfeld, C., Blank, F., Müller, L., Lehmann, A., Brandenberger, C., Rothen‐Rutishauser, B.

“…Recent findings are reported about certain aspects of the structure and function of the mammalian and avian lungs that include (a) the architecture of the air…”
Get full text

Detection of Chromosome Abnormalities Pre–High-Dose Treatment in Patients Developing Therapy-Related Myelodysplasia and Secondary Acute Myelogenous Leukemia After Treatment for Non-Hodgkin’s Lymphoma by LILLINGTON, Debra M, MICALLEF, Ivana N. M, CARPENTER, Emily, NEAT, Michael J, AMESS, John A. L, MATTHEWS, Janet, FOOT, Nicola J, YOUNG, Bryan D, LISTER, T. Andrew, ROHATINER, Ama Z. S

“…To assess whether pre-high-dose therapy (HDT)-related factors play a critical role in the development of therapy-related myelodysplasia (tMDS) or secondary…”
Get full text

The most frequent constitutional translocation in humans, the t(11;22)(q23;q11) is due to a highly specific Alu-mediated recombination by HILL, A. S, FOOT, N. J, CHAPLIN, T. L, YOUNG, B. D

“…The t(11;22) is the most common recurrent non-Robertsonian constitutional translocation in humans, having been reported in more than 160 unrelated families…”
Get full text

Autoimmune cytopenias in the 22q11.2 deletion syndrome by Davies, J. K., Telfer, P., Cavenagh, J. D., Foot, N., Neat, M.

“…Summary We describe two cases of recurrent autoimmune cytopenias, which were subsequently diagnosed with a 22q11.2 deletion/DiGeorge syndrome. The cases are of…”
Get full text

Molecular characterisation of the t(1;15)(p22;q22) translocation in the prostate cancer cell line LNCaP by Strefford, J C, Lane, T M, Hill, A, LeRoux, L, Foot, N J, Shipley, J, Oliver, R T D, Lu, Y-J, Young, B D

“…Although chromosome translocations are well-documented recurrent events in hematological malignancies and soft tissue sarcomas, their significance in…”
Get more information

The characterisation of the lymphoma cell line U937, using comparative genomic hybridisation and multi-plex FISH by Strefford, J C, Foot, N J, Chaplin, T, Neat, M J, Oliver, R T, Young, B D, Jones, L K

“…The cell line U937, which has been used extensively for studies of myeloid differentiation, bears the t(10;11)(p13;q14) translocation which results in a fusion…”
Get more information

Genetic susceptibility to Hodgkin's disease and secondary neoplasias: FISH analysis reveals patients at high risk of developing secondary neoplasia by Lillington, D. M., Micallef, I. N. M., Carpenter, E., Neat, M. J., Amess, J. A. L., Matthews, J., Foot, N. J., Lister, T. A., Young, B. D., Rohatiner, A. Z. S.

“…Background: Cytotoxic drugs administered before high‐dose therapy (HDT) represent a significant factor in the development of leukemic complications in patients…”
Get full text

31P Liquid biopsies in clinical practice by Repana, D., Shanmugalingam, T., Gerrard, G., Foot, N., Kulkarni, A., Naidoo, K., Talukdar, S., Snape, K., Hanson, H., Quigley, K., Mokretar, K., Du Parcq, P., Ferguson, B., Sarker, D., Murugaesu, N.

Get full text

S1612 MOLECULAR MRD STATUS AND OUTCOME AFTER TRANSPLANTATION IN NPM1 MUTATED AML: RESULTS FROM THE UK NCRI AML17 STUDY by Dillon, R., Hills, R., Freeman, S., Potter, N., Jovanovic, J., Kanda, A., Runglall, M., Foot, N., Valganon, M., Raj, K., Khwaja, A., Cavenagh, J., Spearing, R., Ommen, H.B., Overgaard, U.M., Burnett, A., Russell, N., Grimwade, D.

“…Background: Relapse remains the primary cause of treatment failure for patients with acute myeloid leukaemia (AML) who undergo allogeneic stem cell…”
Get full text